Identification of ruxolitinib resistant mutations in Pro-B cells driven by a high-risk B-ALL JAK2-fusion

Research output: Contribution to conference › Poster

Finished
Precision medicine approaches for JAK2-rearranged ALL: The efficacy of targeted therapies and molecular mechanisms of drug resistance
Toomes, C. (Associate Investigator), White, D. L. (Chief Investigator (Project Lead)), McClure, B. (Associate Investigator) & Bruning, J. B. (Associate Investigator)
12/03/18 → 31/12/22
Project: Research

Projects